Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis
- Hongbin Lu 1, Lulu Luo 1, Jie Mi 1, Min Sun 1, Huaping Wang 1, Zheng Wang 2, Wenwen Ding 3
- Hongbin Lu 1, Lulu Luo 1, Jie Mi 1
- 1Department of Hematology, Wuxi Branch of Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Wuxi, Jiangsu, China.
- 2Suzhou Jsuniwell Medical Laboratory, Suzhou, Jiangsu, China.
- 3Department of Oncology, Wuxi Branch of Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Wuxi, Jiangsu, China.
- 0Department of Hematology, Wuxi Branch of Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Wuxi, Jiangsu, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Elevated soluble programmed death protein ligand-1 (sPD-L1) indicates a poorer prognosis for diffuse large B-cell lymphoma (DLBCL) patients, correlating with reduced overall survival and progression-free survival. Higher sPD-L1 is linked to more aggressive disease characteristics.
Area Of Science
- Oncology
- Immunology
- Hematology
Background
- Soluble programmed death protein ligand-1 (sPD-L1) significance in diffuse large B-cell lymphoma (DLBCL) prognosis is debated.
- Previous analyses yielded conflicting results regarding sPD-L1's predictive value.
Purpose Of The Study
- To investigate the prognostic impact of soluble PD-L1 (sPD-L1) expression in patients with DLBCL.
- To clarify the association between sPD-L1 levels and patient survival outcomes.
Main Methods
- A meta-analysis was conducted, searching major scientific databases (Web of Science, PubMed, Embase, CNKI) up to August 14, 2024.
- Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated for overall survival (OS) and progression-free survival (PFS).
- Odds ratios (ORs) and 95%CIs were used to explore associations between sPD-L1 and clinicopathological factors.
Main Results
- Seven studies involving 826 patients were included.
- Elevated sPD-L1 was significantly associated with poor OS (HR = 2.81) and inferior PFS (HR = 3.16) in DLBCL patients.
- Higher sPD-L1 correlated with poor ECOG PS, advanced clinical stage (III-IV), elevated LDH, and high IPI scores (3-5).
Conclusions
- Higher sPD-L1 levels are a significant predictor of poor OS and PFS in DLBCL.
- Elevated sPD-L1 is closely linked to aggressive disease factors in DLBCL, highlighting its potential as a prognostic biomarker.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:31
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:23
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

